Omnio, a Umeå-based #BioTech startup, has raised an #oversubscribed €2.9 million round from existing investors and shareholders to advance its plasminogen-based #therapy for chronic wounds toward clinical studies. 🇸🇪 🧬 🦵
European #VC firm Lakestar announced the closing of its Lakestar Resilience I fund at €262.2 million. The #fund was #oversubscribed and has been built exclusively for dual-use and #defence technology companies. 🇪🇺🪖🚀